ProMIS Neurosciences Inc.
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 11.9 | – | – | – | – | – | – | |
| – | – | – | – | 4,254.6 | 3,607.3 | 8,685.6 | – | – | – | – | 72,834.1 | 99,059.3 | 28,273.4 | – | – | – | – | – | – | – | – | 2,996.9 | 3,246.6 | 4,731.7 | 37,498.1 | – | – | – | – | 5,914.7 | 4,726.1 | 6,229.0 | 5,271.4 | – | – | – | – | – | – | |
| 12.8 | 252.6 | 12.9 | – | 16.3 | 23.4 | 43.5 | 10.6 | 13.3 | 42.6 | 50.5 | 89.6 | – | 85.4 | – | – | – | – | – | – | 5.2 | 5.5 | 7.4 | 4.2 | 31.8 | – | – | – | 2.7 | – | 481.4 | – | 5.4 | 2.0 | 2.6 | – | 1.6 | – | 1.4 | 2.4 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,786.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -11.9% | -10.8% | -11.7% | -7.3% | -9.2% | -12.6% | -5.9% | -7.1% | -9.6% | -12.9% | -11.8% | -13.7% | -11.5% | -14.5% | -18.3% | -10.2% | -15.5% | -19.3% | -7.7% | -8.0% | -11.5% | -27.1% | -30.6% | -37.3% | -48.6% | -59.8% | -53.8% | -56.1% | -59.8% | – | – | – | – | -80.7% | -87.5% | -141.6% | -181.5% | -234.5% | -42.8% | -34.8% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | -28,336.5% | -27,493.8% | -28,979.5% | – | – | – | – | -758,288.8% | -1,070,026.5% | -219,496.4% | – | – | – | – | – | – | – | – | -23,651.6% | -23,589.1% | -25,669.5% | -247,377.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -52,635.8% | -57,681.7% | -64,107.8% | – | – | – | – | -401,122.9% | -436,295.4% | -921,667.4% | – | – | – | – | – | – | – | – | -93,389.0% | -127,494.7% | -265,133.6% | -3,202,397.1% | – | – | – | – | -221,681.1% | -203,705.7% | -234,257.7% | -268,167.0% | – | – | – | – | – | – | |
| – | – | – | – | -61,178.2% | -57,162.2% | -63,386.5% | – | – | – | – | -1,511,416.5% | -2,002,978.1% | -613,689.0% | – | – | – | – | – | – | – | – | -43,825.0% | -66,676.8% | -181,140.2% | -2,512,342.6% | – | – | – | – | -201,418.1% | -194,419.5% | -8,977.7% | 44,284.8% | – | – | – | – | – | – | |
| – | – | – | – | -39,026.1% | -45,631.5% | -51,636.8% | – | – | – | – | -994,458.6% | -1,143,831.8% | -411,308.9% | – | – | – | – | – | – | – | – | -91,771.2% | -121,229.1% | -229,844.7% | -2,241,926.0% | – | – | – | – | – | – | – | -425,504.7% | – | – | – | – | – | – | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -248.2% | -5,006.4% | -254.0% | – | -234.4% | -370.3% | -317.5% | -84.5% | -143.1% | -788.4% | -862.8% | -1,859.1% | – | -1,852.8% | – | – | – | – | – | – | -99.3% | -156.3% | -108.1% | -86.4% | -1,216.2% | – | – | – | -238.6% | – | -16,393.2% | – | -7.7% | 16.9% | -9.9% | – | -318.7% | – | -66.9% | -85.5% | |
| -154.9% | -359.2% | -185.5% | -580.1% | -172.7% | -261.5% | -278.8% | -79.0% | -122.4% | -307.4% | -517.4% | -669.4% | -1,256.9% | -355.7% | -424.2% | -422.2% | -913.0% | -408.9% | -123.4% | -129.9% | -32.7% | -49.8% | -28.0% | -56.9% | -164.9% | -192.7% | -470.3% | -1,053.6% | -90.2% | – | -356.2% | -865.5% | -2.3% | 14.7% | -6.8% | -88.6% | -136.5% | -432.6% | -60.3% | -74.5% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -1.4 | -0.6 | -1.9 | -0.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -3.2 | -23 | -18 | -17 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 62.4% | 7.2% | 73.0% | -8.3% | 73.7% | 70.6% | 87.8% | 93.5% | 85.5% | 39.0% | 60.0% | 36.0% | -126.8% | 19.2% | -12.3% | -34.4% | -289.9% | -73.4% | -92.5% | -112.5% | 32.9% | 31.9% | 25.9% | 65.9% | 13.6% | -19.5% | -139.5% | -569.3% | 37.8% | – | 2.2% | -161.5% | 29.7% | 87.2% | 69.4% | -4.0% | 42.8% | -13.7% | 90.1% | 87.1% | |
| 0.1 | 1.7 | 0.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.4 | 0.5 | 0.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -23.26 | -29.73 | -32.54 | -39.82 | -43.14 | -40.41 | -39.41 | -35.84 | -38.76 | -55.51 | -58.99 | -59.14 | -54.59 | -42.33 | -36.00 | -34.26 | -33.29 | -29.31 | -59.06 | -49.87 | -40.44 | -47.24 | -21.94 | -33.37 | -58.38 | -72.02 | -82.09 | -80.72 | -44.24 | -0.83 | -16.18 | -15.43 | -0.47 | 2.00 | -0.67 | -6.05 | -21.01 | -22.61 | -6.22 | -4.62 | |
| – | – | – | – | 0.07 | 0.07 | 0.06 | – | – | – | – | 0.00 | 0.00 | 0.01 | – | – | – | – | – | – | – | – | 0.05 | 0.05 | 0.03 | 0.00 | -0.02 | -0.02 | -0.02 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 9.37 | 0.59 | 12.81 | -0.57 | 18.40 | 10.91 | 12.41 | 42.41 | 27.08 | 7.04 | 6.84 | 3.18 | -5.51 | 2.28 | -1.04 | -2.79 | -10.57 | -5.26 | -44.25 | -43.18 | 40.72 | 30.23 | 20.29 | 38.64 | 4.80 | -7.28 | -24.35 | -43.61 | 18.54 | – | 0.10 | -2.88 | 6.05 | 11.84 | 6.79 | -0.27 | 6.59 | -0.72 | 9.30 | 5.40 | |
| -14.26 | -16.19 | -19.28 | -22.88 | -27.52 | -32.26 | -32.10 | -31.78 | -34.46 | -38.64 | -40.61 | -38.91 | -31.18 | -28.37 | -24.64 | -24.50 | -25.52 | -23.11 | -19.65 | -20.38 | -24.23 | -44.70 | -45.93 | -60.68 | -74.08 | -64.27 | -63.25 | -54.74 | -29.92 | – | – | – | – | -19.17 | -15.31 | -16.99 | -19.51 | -15.94 | -5.43 | -4.59 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.